Shifting from population-wide to personalized cancer prognosis with microarrays.
The era of personalized medicine for cancer therapeutics has taken an important step forward in making accurate prognoses for individual patients with the adoption of high-throughput microarray technology.However, microarray technology in cancer diagnosis or prognosis has been primarily used for the statistical evaluation of patient populations, an